Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy

PURPOSE: Reactive oxygen species modulator 1 (Romo1) is a novel protein that regulates the production of intracellular reactive oxygen species. Romo1 has been shown to be associated with poor survival in various clinical settings for the treatment of lung cancer. In this study, we evaluated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwack, Won Gun, Sung, Ji-Youn, Lee, Seung Hyeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695430/
https://www.ncbi.nlm.nih.gov/pubmed/34956890
http://dx.doi.org/10.3389/fonc.2021.770230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695430/
https://www.ncbi.nlm.nih.gov/pubmed/34956890
http://dx.doi.org/10.3389/fonc.2021.770230

Ejemplares similares